Tech Company Financing Transactions

Avila Therapeutics Funding Round

Private investors participated in a $5 million venture round for Avila Therapeutics. The round was announced on 5/18/2009.

Transaction Overview

Company Name
Announced On
5/18/2009
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
45 Wiggins Ave.
Bedford, MA 01730
USA
Email Address
Overview
Avila Therapeutics, Inc., is a venture-backed company focused on the discovery and development of novel small molecule therapeutics to address significant unmet clinical needs with an initial focus on cancer and viral diseases.
Profile
Avila Therapeutics LinkedIn Company Profile
Social Media
Avila Therapeutics Company Twitter Account
Company News
Avila Therapeutics News
Facebook
Avila Therapeutics on Facebook
YouTube
Avila Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Katrine Bosley
  Katrine Bosley LinkedIn Profile  Katrine Bosley Twitter Account  Katrine Bosley News  Katrine Bosley on Facebook
Chief Scientific Officer
Juswinder Singh
  Juswinder Singh LinkedIn Profile  Juswinder Singh Twitter Account  Juswinder Singh News  Juswinder Singh on Facebook
VP - Operations
Nagesh Mahanthappa
  Nagesh Mahanthappa LinkedIn Profile  Nagesh Mahanthappa Twitter Account  Nagesh Mahanthappa News  Nagesh Mahanthappa on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/18/2009: StockTwits venture capital transaction
Next: 5/19/2009: Elixir Pharmaceuticals venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary